---
title: "Pfizer Recalls Nurtec ODT Prescription Drugs Due to Failure to Meet Child Res... — CPSC recall 23154 | Is It on Recall"
description: "The recalled prescription drugs must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is"
url: https://isitonrecall.com/recall/cpsc-23154-pfizer-recalls-nurtec-odt-prescription-drugs-due-to-failure-to-meet-child-resistant-packaging-requir/
updated: 2026-10-01
site: "Is It on Recall"
language: en
---

[Recall archive](https://isitonrecall.com/archives/) / CPSC

# Pfizer Recalls Nurtec ODT Prescription Drugs Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Po... — CPSC recall 23154

Published notice; closure not supplied

The CPSC record supplies a notice and remedy, not a current closure determination.

Source date Mar 16, 2023. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; [check FSIS directly](https://www.fsis.usda.gov/recalls). [Source coverage and dates](https://isitonrecall.com/sources/).

## What the record says

- **Product**: This recall involves prescription drugs Nurtec ODT 75 mg orally disintegrating tablets sold in cartons containing one blister card of 8 tablets. The tablets are in a non-child resistant blister card packaged in a carton that includes the name of the product, dosage strength, expiration date. The dosage strength and expiration date are printed or stamped on the blister card. The recall includes the following: Product Description NDC Number Expiration Date Nurtec® ODT (rimegepant) 75mg 8-Unit Dose blister pack 72618-3000-2 All dates through 6/2026
- **Reason**: The recalled prescription drugs must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistant, posing a risk of poisoning if the contents are swallowed by young children.
- **Classification**: Not supplied
- **Recalling firm**: Biohaven Pharmaceuticals Inc., of New Haven, Conn.; Pfizer Inc., of New York
- **Quantity**: About 4.2 million
- **Agency-reported status**: Published recall notice
- **Source record identifier**: 23154

[Open the official record](https://www.cpsc.gov/Recalls/2023/Pfizer-Recalls-Nurtec-ODT-Prescription-Drugs-Due-to-Failure-to-Meet-Child-Resistant-Packaging-Requirement-Risk-of-Poisoning)

## Lot and product identifiers

| Label field | Details supplied by the agency |
| --- | --- |
| Lot, code or applicability | Read the product description and official photos for model and lot identifiers. |

Match all identifying details in the current notice. A brand name alone is not enough.

## Distribution

Not supplied

No US distribution state could be established from this record. Check the official notice.

## Dates in the source

- **Last publish date**: Mar 16, 2023

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

## What to do next

Consumers should immediately secure the recalled product out of the sight and reach of children and contact Pfizer for a free child resistant pouch to store the product. Once the product is secured, consumers can continue to use it as directed.

[Read the current instructions](https://www.cpsc.gov/Recalls/2023/Pfizer-Recalls-Nurtec-ODT-Prescription-Drugs-Due-to-Failure-to-Meet-Child-Resistant-Packaging-Requirement-Risk-of-Poisoning)

### Contact in the notice

Pfizer at 800-879-3477 Monday through Friday 9 a.m. to 7 p.m. ET, online at www.pfizer.com/contact or online at www.Nurtec.com/PackagingUpdate or www.Nurtec.com and click "Recall to provide child resistant pouches to patients for storage of their medicine. Click for details" for more information.

## Related records

[Other consumer products records](https://isitonrecall.com/category/other-consumer-products/) [Biohaven Pharmaceuticals Inc., of New Haven, Conn.; Pfizer Inc., of New York records](https://isitonrecall.com/brand/biohaven-pharmaceuticals-inc-of-new-haven-conn-pfizer-inc-of-new-york/)